ACS03

Overview

ACS03 is a hybrid thiophene-acridine compound. ACS03 induces an increase in lactate dehydrogenase , glutathione S-transferase , and AChE activities. ACS03 has antileishmanial activity. ACS03 exhibits selective anti-cancer effects against colon carcinoma.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Parasitic Infection | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Leishmania Infection | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Lactate Dehydrogenase | Products > Signaling Pathways > Glutathione S-transferase | Products > Signaling Pathways > Cholinesterase (ChE) | Products > Signaling Pathways > Parasite

Product Information

• Catalog No.: HY-177958
• CAS No.: 2227022-64-0
• Molecular Formula: C24H20ClN3OS
• Molecular Weight: 433.95
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source